201 related articles for article (PubMed ID: 23650540)
1. Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia.
Fognani E; Giannini C; Piluso A; Gragnani L; Monti M; Caini P; Ranieri J; Urraro T; Triboli E; Laffi G; Zignego AL
PLoS One; 2013; 8(5):e62965. PubMed ID: 23650540
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role.
Zignego AL; Ferri C; Giannini C; La Civita L; Careccia G; Longombardo G; Bellesi G; Caracciolo F; Thiers V; Gentilini P
Arch Virol; 1997; 142(3):545-55. PubMed ID: 9349300
[TBL] [Abstract][Full Text] [Related]
3. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
4. Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.
Cacoub P; Bourlière M; Hausfater P; Charlotte F; Khiri H; Toci S; Piette JC; Poynard T; Halfon P
J Viral Hepat; 2003 Jan; 10(1):10-5. PubMed ID: 12558906
[TBL] [Abstract][Full Text] [Related]
5. HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia.
De Re V; Caggiari L; Monti G; Libra M; Spina M; Dolcetti R; De Zorzi M; Racanelli V; Crovatto M; Toffoli G
Tissue Antigens; 2010 Feb; 75(2):127-35. PubMed ID: 20002609
[TBL] [Abstract][Full Text] [Related]
6. Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.
Libra M; Mangano K; Anzaldi M; Quattrocchi C; Donia M; di Marco R; Signorelli S; Scalia G; Zignego AL; de Re V; Mazzarino MC; Nicoletti F
Oncol Rep; 2006 May; 15(5):1305-8. PubMed ID: 16596202
[TBL] [Abstract][Full Text] [Related]
7. miRNA-26b downregulation in peripheral blood mononuclear cells of patients with hepatitis C associated lymphomas is restored by successful interferon-free antiviral therapy.
Peveling-Oberhag J; Bankov K; Dultz G; Ballo O; Lohmeyer J; Brunnberg U; Marcu V; Walter D; Zeuzem S; Hansmann ML; Welzel TM; Vermehren J
Antivir Ther; 2019; 24(6):437-442. PubMed ID: 31180334
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
Ghinoi A; Mascia MT; Puccini R; Ferri C
G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
[TBL] [Abstract][Full Text] [Related]
9. Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection.
Terrier B; Chaara W; Dufat L; Geri G; Rosenzwajg M; Musset L; Sène D; Saadoun D; Six A; Klatzmann D; Cacoub P
Autoimmun Rev; 2014 Mar; 13(3):319-26. PubMed ID: 24220267
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor.
Liao TL; Chen YM; Hsieh SL; Tang KT; Chen DY; Yang YY; Liu HJ; Yang SS
mBio; 2021 Dec; 12(6):e0276421. PubMed ID: 34724826
[TBL] [Abstract][Full Text] [Related]
11. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.
Realdon S; Pontisso P; Adami F; Trentin L; Noventa F; Ferrari A; Migliorato I; Gatta A; Alberti A
J Hepatol; 2001 May; 34(5):723-9. PubMed ID: 11434619
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
13. Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.
Gragnani L; Piluso A; Urraro T; Fabbrizzi A; Fognani E; Petraccia L; Genovesi A; Giubilei L; Ranieri J; Stasi C; Monti M; Zignego AL
Curr Drug Targets; 2017; 18(7):772-785. PubMed ID: 26853322
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma.
Caviglia GP; Sciacca C; Abate ML; Olivero A; Rosso C; Touscoz GA; Ciancio A; Rizzetto M; Smedile A
J Gastroenterol Hepatol; 2015 Apr; 30(4):742-7. PubMed ID: 25351042
[TBL] [Abstract][Full Text] [Related]
15. CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia.
Russi S; Vincenti A; Vinella A; Mariggiò MA; Pavone F; Dammacco F; Lauletta G
Eur J Intern Med; 2019 Aug; 66():48-56. PubMed ID: 31126779
[TBL] [Abstract][Full Text] [Related]
16. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation.
Sansonno D; De Vita S; Cornacchiulo V; Carbone A; Boiocchi M; Dammacco F
Blood; 1996 Dec; 88(12):4638-45. PubMed ID: 8977256
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
18. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
19. Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia.
Basile U; Marino M; Gragnani L; Napodano C; Gulli F; Pocino K; Lorini S; Santini SA; Basile V; Miele L; Zignego AL; Rapaccini GL
J Immunol Methods; 2020 Jan; 476():112687. PubMed ID: 31669506
[TBL] [Abstract][Full Text] [Related]
20. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
